183 related articles for article (PubMed ID: 21486537)
1. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
[TBL] [Abstract][Full Text] [Related]
2. In vivo near-infrared fluorescence imaging of integrin α2β1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe.
Huang CW; Li Z; Conti PS
J Nucl Med; 2011 Dec; 52(12):1979-86. PubMed ID: 22065876
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.
Huang CW; Li Z; Cai H; Chen K; Shahinian T; Conti PS
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1313-22. PubMed ID: 21350963
[TBL] [Abstract][Full Text] [Related]
4. Potent oncolytic activity of human enteroviruses against human prostate cancer.
Berry LJ; Au GG; Barry RD; Shafren DR
Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
[TBL] [Abstract][Full Text] [Related]
5. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor.
Burnett CA; Xie J; Quijano J; Shen Z; Hunter F; Bur M; Li KC; Danthi SN
Bioorg Med Chem; 2005 Jun; 13(11):3763-71. PubMed ID: 15863003
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
[TBL] [Abstract][Full Text] [Related]
8. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
Themelis G; Harlaar NJ; Kelder W; Bart J; Sarantopoulos A; van Dam GM; Ntziachristos V
Ann Surg Oncol; 2011 Nov; 18(12):3506-13. PubMed ID: 21509632
[TBL] [Abstract][Full Text] [Related]
9. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.
Zitzmann S; Mier W; Schad A; Kinscherf R; Askoxylakis V; Krämer S; Altmann A; Eisenhut M; Haberkorn U
Clin Cancer Res; 2005 Jan; 11(1):139-46. PubMed ID: 15671538
[TBL] [Abstract][Full Text] [Related]
10. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
Zheng X; Xing D; Zhou F; Wu B; Chen WR
Mol Pharm; 2011 Apr; 8(2):447-56. PubMed ID: 21197955
[TBL] [Abstract][Full Text] [Related]
12. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
13. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
14. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands.
Becker A; Hessenius C; Licha K; Ebert B; Sukowski U; Semmler W; Wiedenmann B; Grötzinger C
Nat Biotechnol; 2001 Apr; 19(4):327-31. PubMed ID: 11283589
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
16. Integrin α2β1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging.
Hu H; Li D; Liu S; Wang M; Moats R; Conti PS; Li Z
Biomaterials; 2014 Oct; 35(30):8649-58. PubMed ID: 25043573
[TBL] [Abstract][Full Text] [Related]
17. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
[TBL] [Abstract][Full Text] [Related]
19. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
Hall CL; Dai J; van Golen KL; Keller ET; Long MW
Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
